- Revance to Participate in the RBC Capital Markets 2019 Healthcare Conference
- Revance Reports First Quarter 2019 Financial Results and Provides Corporate Update
- Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019
- Revance Appoints Former Allergan Marketing Veteran Taryn Conway as Vice President of Marketing
- SAKURA 3 Trial Results Presented on Podium at World’s Largest Medical Aesthetic Conference
- Revance to Participate in the Needham Healthcare Conference
- Revance to Participate in Upcoming Investor Conferences
- Revance Releases Fourth Quarter and Full Year 2018 Results
Revance Therapeutics Inc (RVNC:NMQ) closed at 11.90, 13.23% above the 52 week low of 10.51 set on May 09, 2019.
10.51May 09 201932.45Jun 12 2018
Markit short selling activity
|Market cap||523.68m USD|
|EPS (TTM)||-3.81 |
Data delayed at least 15 minutes, as of May 17 2019 21:00 BST.